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Non-coding RNAs (ncRNAs)Gene expression is controlled through a complex interplay among mRNAs, non-coding RNAs and
RNA-binding proteins (RBPs), which all assemble along with other RNA-associated factors in
dynamic and functional ribonucleoprotein complexes (RNPs). To date, our understanding of RBPs
is largely limited to proteins with known or predicted RNA-binding domains. However, various
methods have been recently developed to capture an RNA of interest and comprehensively identify
its associated RBPs. In this review, we discuss the RNA-afﬁnity puriﬁcation methods followed by
mass spectrometry analysis (AP-MS); RBP screening within protein libraries and computational
methods that can be used to study the RNA-binding proteome (RBPome).
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In recent years, our understanding of the emerging role of
RNA–protein interactions in regulating and coordinating gene
expression has substantially evolved. The outcome was a renewed
interest in post-transcriptional regulation and elucidation of the
components of ribonucleoprotein complexes (RNPs).
Ribonucleoprotein (RNP) particles are composed of one or more
RNA molecules and at least one protein, and can vary in size from
the large ribosome to the small nuclear RNPs (snRNPs). Some form
stable functional structures, whereas others, such as the eukaryotic
spliceosome [1], are assembling and disassembling in a spectacu-
larly dynamic manner during their functional cycle. The collection
of RNPs within a cell composes the ribonome, which can be
described as a highly sophisticated, self-sustaining and self-limit-
ing regulatory system that inextricably interconnects the tran-
scriptome and the proteome [2]. The ribonome, in mammalian
cells, consists of thousands messenger RNPs (mRNPs) that contain
mRNAs and their associated non-coding RNAs along with RNA-
binding proteins (RBPs) and auxiliary proteins.
Post-transcriptional events such as RNA metabolism, process-
ing, transport, translation and storage are regulated by RBPs
[3–5]. Eukaryotic RNAs are dynamically organized into different
RNP structures, and all these structures are needed for RNAtranscription, processing and function. For example, pre-mRNA
processing steps involving splicing, editing and polyadenylation
are mediated by RBPs as soon as pre-mRNAs emerge from the
RNA polymerase [6–8]. After these processing steps, the mRNAs
are exported to the cytoplasm by nuclear pores through the forma-
tion in the nucleus of an mRNP export complex that is capable of
shuttling back and forth through the nuclear pores [9]. Complexes
consisting of motor proteins and RBPs, or even the signal recogni-
tion particle, may further contribute to localization of RNAs to spe-
ciﬁc subcellular regions [10,11]. Thereby, transport of mRNAs has
to be accompanied by translational repression, which is mediated
by certain RBPs [12,13].
Quantitative genomic, proteomic and microscopy analyses have
recently given rise to the ﬁeld of RNP biology. The functions of
some RBPs have been characterized on the basis of RNA-binding
and regulatory elements in their sequence, as well as through the
analysis of their associated tissue-speciﬁc expression proﬁles.
These approaches have revealed protein–nucleic acid and pro-
tein–protein interactions within RNPs, as well as mRNP protein
localization, dynamics and processing. However, very little is
known about how RBPs control constitutive expression patterns.
For example, the study of RBPs involved in large RNA–protein com-
plexes that regulate mRNA metabolism is difﬁcult owing to the
plasticity and complexity of these systems.
Currently, only a few RNPs have been studied extensively and
the function of most RBPs can only be predicted on the basis of
sequence similarity. A fundamental question has been how to
determine the role of each RNP component. Elucidation of these
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centric methods the goal is the identiﬁcation of RNAs that are
bound to a known protein, whereas in RNA-centric methods the
aim is the identiﬁcation of proteins associated with an RNA of
interest.
In this review, we overview the biochemical and genetic strate-
gies that have been developed in recent years to identify proteins
that bind to a speciﬁc RNA target in a genomic scale, without prior
knowledge of protein candidates. In particular, we consider the
advantages and disadvantages of the main methods described,
focusing on the subtypes of RNA that can be investigated. This
review does not cover methods implicated in the analysis of RNAs
associated to a precise RNP; excellent reviews of these topics can
be found in literature [14–16].
2. Focus on the RBPome
The RBPome can be deﬁned as the interface where RNA and
RBPs meet, for controlling many aspects of gene regulation
[8,17]. RNA–protein complexes are very dynamic and can undergo
extensive remodelling. Therefore, they can control the pattern and
spatiotemporal regulation of various sets of genes, including genes
that are involved in cell cycle progression, cell differentiation,
organ morphogenesis and embryonic development. Consistent
with their physiologic importance, perturbation of RBP expression
or function has been linked to several diseases, including metabolic
and neurological disorders, muscular atrophies, fragile X syn-
drome, autoimmune pathologies and cancer [18,19].
2.1. Conserved RBP domains
The number and variety of RBPs, especially of metazoan RBPs,
that are reported in the literature are rapidly expanding [20,21].
Eukaryotic cells encode a large number of RBPs that allows them
to combine with each RNA in unique forms to generate a vast
plethora of RNPs [22].
The majority of eukaryotic RBPs contain unique RNA-binding
and protein–protein interaction domains. RBPs bind RNA through
a large set of protein domains, including RNA recognition motifs
(RRMs); zinc ﬁngers; K homology (KH) domains; serine arginine
(SR domains); Sm domains; double stranded RNA-binding domains
(dsRBDs); DEAD/DExH-box helicase (DEAD-box) motifs; and less
common domains, such as Piwi/Argonaute/Zwille (PAZ) and Pumi-
lio/FBF (PUF) domains. Thus, a large number of proteins have been
predicted to be RBPs based on the presence of these commonly
occurring RNA-binding domains. Accordingly, in the nematode,
Caenorhabditis elegans, it has been predicted that as many as 887
genes may encode RBPs [23]. In the yeast, Saccharomyces cerevisiae,
approximately 600 transcripts are reported to code for putative
RBPs, as well as almost one quarter of annotated human genes
[24,25].
Although domain conservation has been used to identify several
RBPs in different organisms, targets of these RBPs are poorly under-
stood. A high degree of modularity exist at the structural level, in
RBPs, as most contain multi-domains composed of at least one
RNA-binding and auxiliary domains that can promote RBP interac-
tions with other proteins. This modularity generates both multiva-
lent RNA speciﬁcity and functional diversity within the RBPs [26].
Indeed, evidence suggests that RBPs are multi-targeted [27–29].
2.2. RBP modularity
The multi-targeted function of RBPs has led to the introduction
of a post-transcriptional RNA operon (PTRO) model for the regula-
tion of eukaryotic gene expression [30]. The PTRO model proposes
that RBPs in eukaryotes coordinate groups of mRNAs coding forfunctionally related proteins. Correlation between polycistronic
mRNAs from bacterial operons and the regulation of multiple mon-
ocistronic mRNAs by RBPs has led to this theory. The PTRO model
proposes that RBPs in eukaryotes coordinate groups of mRNAs cod-
ing for functionally related proteins. These RNA regulons function
on the basis of an RNP-driven process, in which multiple trans-act-
ing factors, such as RBPs, non-coding RNAs (ncRNAs) and metabo-
lites, bind cis-acting elements within their mRNA targets. Multiple
cis-regulatory elements on each mRNA results in a modular USER
(untranslated sequence element for regulation) code [22]. These
USER codes determine the association of speciﬁc RNA-binding fac-
tors with each mRNA in order to cooperate or compete to the reg-
ulatory fate of that molecule. Within the ribonome, each mRNA
exists in different forms dictated by the multiple activities and
compositions of RNPs that controls the stability or translatability
of the mRNA in response to cellular signals. Thus in a concerted
manner the RBPs can regulate multiple mRNA targets as well as
one another’s mRNAs within the ribonome.
Studies on RNP within different species indicate that the same
RBP can bind mRNAs encoding proteins with similar functions
[31]. The most studied example of a post-transcriptional RNA
operon was that originally described by Gerber et al. which exam-
ined ﬁve Pumilio RBP family members in yeast and found a sub-
population of mRNAs encoding proteins with related functions
bound by the RBPs [32,33].
Strong evidence for widespread regulation at the post-tran-
scriptional level arises from selective binding of RBPs to sets of
mRNAs encoding functionally related proteins. Similarly, an impor-
tant role for cell maintenance can be hinted by RBPs function in
creating and maintaining spatial organization in the cell, upon
combining protein production and mRNA decay in the same loca-
tion [34,35]. By the organization of monocistronic mRNA in func-
tional groups, RNA regulons are responsible for the temporal and
spatial coordination between the co-transcriptional and post-
transcriptional regulation of gene expression. In this context, the
post-transcriptional operon model can be used to explain the
discrepancy that is often observed between mRNA transcript levels
and the ﬁnal amount of protein produced.
The only way to decipher the RNA operon code and the role of
individual RBPs in post-transcriptional regulation will be through a
mechanistic characterization of RBPs binding preferences.
Recent developments in high-throughput technologies, such as
CLIP [36], RIP-ChIP [37] and the RNAcompete assay [38] have
allowed for the identiﬁcation of RNA targets of RBPs in a gen-
ome-wide manner [39–41]. These methods work on a similar con-
cept where the RBP complex together with its target RNAs is ﬁrst
extracted and then the target RNA identiﬁed by microarray or
sequencing analysis. Computational approaches, such as RBPmap
[42] and RNAcontext [43] have been developed for accurate predic-
tion and mapping of transcriptome-wide RBP binding sites. RBPs
typically bind RNAs in a sequence-speciﬁc manner, interacting
with degenerate and/or short sequence motifs [44]. However,
sequence analysis is not sufﬁcient to predict the binding sites or
RNA targets of RBPs, as the motifs do not contain enough informa-
tion. Indeed, it is generally believed that other factors, such as the
accessibility of binding sites within folded RNA molecules or the
clustering of binding sites which may allow for binding of RBP
multimers or multidomain RBPs contribute to their speciﬁcity
[45,46]. In addition, some RBPs bind indiscriminately along tran-
scripts, and this complicates the prediction of the binding speciﬁc-
ity of RBPs.
Protein-centric approaches can identify most RNA targets of an
RBP, independent of prior knowledge of phenotypes or expression
proﬁles, and uncover mRNA targets from functionally paralogous
genes co-regulated by an RBP [47]. Although useful information
regarding the location of the RNA sequence interacting with
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tion of protein partners that bind to a speciﬁc RNA remains
challenging.
3. RNA-centric approaches for RBPome analysis
The characterization of the RBPome associated to a given RNA of
interest is a fundamental area of exploration in elucidating post-
transcriptional networks. The same RNA can be bound and regu-
lated by multiple factors as indicated by several studies comparing
multiple RBPs and their targets [24,48]. Multiple RBPs can associ-
ate with a single RNA simultaneously or sequentially and a single
RBP or non-coding RNA can potentially target a large number of
different RNA species [49–52]. The cooperation and competition
among these factors result in the combinatorial regulation of a
given message. Understanding the remodelling of the RBPs prote-
ome will provide great insight into the dynamic interplay of RNAs
and RBPs during an mRNA life cycle.
RNA-centric approaches have been widely used to gain initial
insights into RBPs that cooperate for functional regulation of a
given RNA or class of RNAs, including mRNAs and ncRNAs. The
overall aim of these approaches is to predict the functional conse-
quences of numerous RNA–protein interactions that take place
sequentially or simultaneously on a target RNA. Compared with
protein-centric methods that employ top-down approaches to
study RNA interactions of individual RBPs using the protein as
the bait in enrichment steps, RNA-centric methods employ tagged
RNA as the bait in order to identify proteins interacting with it.
Moreover, these methods can be used to analyse the cooperative,
independent or competitive association of different proteins with
the same mRNA.Table 1
RNA-centric methods to identify novel RBPs.
Category RNA afﬁnity capture and MS analysis
Description In vivo and in vitro approaches to identify RBPs associated to an RN
interest through immobilization of the bait RNA into a chromatogra
matrix. After a series of washing steps to remove non-speciﬁcally bo
proteins, the RNP complexes are eluted from the solid support and
subjected to mass spectrometry analysis
Protocols  TRAP
 RAT
 MS2-BioTRAP
 RaPID
 Csy4 system
 Interactome capture
 PAIR
 RiboTrap
 CHART
 4  S1m
 ChIRP
 Afﬁnity medium
 MS2-TRAP
 RNase-assisted
Advantages  Easy puriﬁcation steps
 Applicable to mammalian cells
 Possibility to study RNA–protein interaction under physiolo
conditions
 Flexibility and versatility
Disadvantages  High background noise
 Perturbation of RNA folding trough the insertion of tags
 Involves challenging design of antisense oligonucleotide
 Large amounts of starting material required
 Time-consuming
 Identiﬁcation of only relatively abundant proteins
 Limited throughput
 Involves challenges associated with transfection of cells
References [56,57,60,62,64,65,67–69,72,86–88,91–93]
Abbreviations: TRAP, Tandem RNA afﬁnity puriﬁcation; RAT, RNA afﬁnity in tandem; MS2
protein puriﬁcation and identiﬁcation; PAIR, Peptide nucleic acid-assisted identiﬁcation
isolation by RNA puriﬁcation; MS2-TRAP, MS2-tagged RNA afﬁnity puriﬁcation; Y3H, ThThese methods can be sub-divided into two main categories:
RNA-afﬁnity puriﬁcation followed by mass spectrometry analysis
(RAP-MS) assays; and RBP screening within protein libraries
(Table 1).
4. RNA-afﬁnity puriﬁcation assays
RNA-afﬁnity-based RBP puriﬁcation is a versatile strategy that
allows for the identiﬁcation of RNA–protein interactions in both
subcellular compartments and in vivo systems. This technique is
particularly suited for studying RNA–protein interactions that are
dictated by the formation of multi-protein complexes, as it facili-
tates the study of individual interactions within these larger
molecular frameworks. RNA-afﬁnity puriﬁcation is an excellent
method to purify RNP complexes from mammalian cells, in which
post-transcriptional modiﬁcations, such as phosphorylation, are
often used by regulatory proteins to increase or decrease the afﬁn-
ity for their targets. Finally, coupled with cross-linking, RNA-afﬁn-
ity puriﬁcation has the ability to capture both stable and transient
interactions. One advantage of RNP cross-linking, used on in vivo
or in vitro-assembled complexes, is the potential to maintain a
stable composition of RNP complexes even under the stringent
washing conditions that are required for reducing the isolation of
non-speciﬁcally-binding proteins.
In RNA-afﬁnity capture-based approaches, RNP complexes are
assembled in vitro or in vivo, and the bait RNA from cell/tissue
lysates is immobilized to a solid support either covalently or
non-covalently. Then, following a series of washing steps to
remove non-speciﬁcally bound proteins, the RNP complexes are
released from the chromatographic matrix and subjected to mass
spectrometry (MS) analysis (Fig. 1).RBP screening within protein libraries
A of
phic
und
In vivo and in vivo systems to detect and analyse RBPs that interact with a
known RNA. By providing a link between each protein of a cDNA library
and its encoding gene, clones with desirable features are subjected to
iterative rounds of selection and ampliﬁcation
 Phage display
 mRNA display
 Bacterial antitermination assay
 Northwestern
 Y3H
 Protein microarray
 IVC
 Tat-hybrid system
gical
 Some of these methods can be used to study interactions in vivo
 High sensitivity
 High-throughput
 Minimal amounts of starting material required
 Ampliﬁcation of detection
 Time-consuming
 High number of false positives
 Some of these methods are limited to binary interactions
 No direct correlation between protein abundance and activity
 With some methods, interactions are studied under artiﬁcial
conditions
[72,74,79,81,85,88,92]
-BioTRAP, MS2 in vivo biotin tagged RNA afﬁnity puriﬁcation; RaPID, RNA-binding
of RBPs; CHART, Capture hybridization analysis of RNA targets; ChIRP, Chromatin
ree-hybrid system; IVC, In vitro compartmentalization.
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RNA and these can be grouped into two major classes depending
on the strategy used for RNA immobilization to chromatographic
support: tagged RNA afﬁnity puriﬁcation; and antisense RNA-
based afﬁnity puriﬁcation approaches.
4.1. RNA-tag capture
In RNA-tag-mediated puriﬁcation approaches, in vitro-synthe-
sized RNA is chemically tagged through the incorporation of
modiﬁed ribonucleotides that contain biotin, ﬂuorescent dyes,
digoxeginin or other compounds. The high afﬁnity of biotin toFig. 1. RNA afﬁnity capture and proteomic analysis. In vitro approaches. Ribonucleoprote
RNA of interest, which has been immobilized on a solid support. After several washing ste
and subjected to proteomic analysis. In vivo approaches. Cells are UV irradiated (c-CL
physiological RNA–protein interactions. Cells are lysed and the ribonucleoprotein compl
bound complexes are eluted and released from the RNA (by heating the sample or by
approaches, samples are usually separated by gel electrophoresis and speciﬁc protein bstreptavidin has made this association a widely used tool for afﬁn-
ity chromatography chosen by many researchers [53,54]. However,
one important drawback of chemical RNA labelling is that in some
cases the chemical modiﬁcations can affect the secondary struc-
ture of RNA, leading to structural rearrangements that interfere
with complex formation.
Alternatively, numerous natural or artiﬁcial aptamers can be
incorporated within the RNA during in vitro or in vivo transcrip-
tion. Aptamers are functional oligonucleotide sequences that have
the ability to bind speciﬁcally and with high afﬁnity to proteins,
peptides and other small molecules [55]. S1 and D8 aptamers are
among the most popular artiﬁcial aptamers used in ribonomicin complexes are assembled using cell lysates in vitro in the presence of the tagged
ps that remove non-speciﬁc interactions, speciﬁc RBPs are released from the support
(254 nm) or PAR-CL (365 nm)) or treated with formaldehyde in order to ‘‘freeze’’
exes are captured from solution. After washing to remove non-speciﬁc proteins, the
RNase digestion). Finally the proteins are subjected to proteomic analysis. In both
ands are excised, digested with proteases and identiﬁed by tandem LC–MS–MS.
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to obtain a sequence with high binding afﬁnity to Sephadex and
Streptavidin afﬁnity matrices respectively [56,57]. Since then, the
streptavidin aptamer D8 has been used to purify ribonuclease P
(RNase P) from S. cerevisiae, and even the ribosome [58]. The
Sephadex aptamer S1 has been used to study the S. cerevisiae
RNase P with a differential protein composition between the pre-
cursor and mature forms of the RNP complex [59].
Well-characterized protein-binding RNA sequences can also be
incorporated as aptamers within the RNA to isolate RBPs. The RNA
tagging most widely used for identiﬁcation of RNA–protein inter-
action is the bacteriophage MS2 coat protein and its cognate RNA
[60,61]. The limiting step when using the MS2 RNA–protein inter-
action in the afﬁnity puriﬁcation is elution of the puriﬁed complex
under native conditions due to the high binding afﬁnity of the
interaction. A way to overcome this restriction is to fuse to the
MS2 coat protein to an additional peptide, such as the maltose-
binding peptide (MBP) [62]. Alternatively, in some studies a prote-
ase cleavage site was inserted between the MS2 coat protein and
the other protein [58].
However, there are some limitations to the broad use of apta-
mers. The incorporation of a foreign sequence to the RNA bait
may alter the RNA structure and possibly the formation and com-
position of the RNP complex. In addition, if there is no structural
information regarding the target RNA it can be difﬁcult to predict
the best position for insertion of the aptamer tag. Moreover, when
used in a cellular context, efﬁciency of artiﬁcial aptamers decreases
inevitably as their lifetime is drastically reduced owing to their
degradation by nucleases. Thereby, the recovery yield of RBPs
might be low but could be improved using nuclease-resistant apta-
mers or scaffold technology [63].
4.2. Antisense RNA capture
Antisense RNA-based afﬁnity puriﬁcation approaches represent
another powerful tool for analysing the protein components of
RNPs. The structure and function of small nuclear ribonucleopro-
tein (snRNP) complexes have been studied using antisense oligo-
nucleotides [64] and later they were adapted and modiﬁed for
the puriﬁcation of a variety of RNPs, including the telomerase
[65] and more recently, the protein components of the small nucle-
olar ribonucleoprotein (snoRNP) complex MBII-52 [66].
Afﬁnity-tagged antisense oligonucleotides can be easily immo-
bilized onto a chromatographic support, using the streptavidin–
biotin interaction, to isolate the RNA bait and its associated pro-
teins. In this case there is no requirement for chemical or sequence
modiﬁcation of the RNA of interest. The resulting complex can then
be eluted either under denaturing conditions, or via a competitor
oligonucleotide. This allows for RBP release under native condi-
tions. However, the design of antisense oligonucleotides with high
afﬁnity to accessible single-stranded regions of highly structured
RNAs is often a challenging step in this approach [67].
Depending on the type of detection and application required,
each of these methods for the tagging and afﬁnity puriﬁcation of
RNA molecules provides different advantages and limitations that
must be considered. Recently developed afﬁnity puriﬁcation meth-
ods have provided a deep understanding of the higher-ordered
structures of multi-subunit RNPs that are often low-abundance
macromolecular complexes.
5. RNA afﬁnity-based strategies for RNP characterization
One important variable in large-scale RNP analysis is the
method used to deﬁne the RBP population that bound a given
RNA. A number of different strategies have been developed toisolate RNPs by using RNA-centric afﬁnity puriﬁcation methods.
All existing protocols involve a similar concept but differ with
regard to the speciﬁc procedure used for purifying RBP–RNA com-
plexes and characterizing target RBPs. All strategies can be used to
successfully isolate RBPs, but each method presents distinct difﬁ-
culties that requires special consideration when designing the
experiments.
5.1. Tandem RNA afﬁnity puriﬁcation (TRAP)
Tandem RNA afﬁnity puriﬁcation (TRAP) tagging is a two-step
afﬁnity puriﬁcation method developed by Krause and colleagues
that facilitates puriﬁcation of RNAs along with their associated
proteins, RNAs and other small molecules [68]. The TRAP-tag
method enables through the use of two RNA tags the puriﬁcation
of RBPs by approximately a million-fold, reducing signiﬁcantly
the chance for contaminants to be retained in the eluate. The
sequence of the RNA of interest is tagged at its 50 or 30 end with
two different tags, one sequence must interact with a ligand in a
reversible manner without disrupting the RNA–protein complex
formed on the target RNA sequence. Functional complexes contain-
ing the double-tagged RNA are often puriﬁed from cell extracts
using a tandem afﬁnity puriﬁcation exploiting each of the tags.
5.2. RNA afﬁnity in tandem (RAT)
Hogg and Collins have characterized the composition of the 7SK
RNP using an approach similar to TRAP, namely the RNA afﬁnity in
tandem (RAT) technique [69]. The high efﬁciency of the RAT is lar-
gely due to further optimization of afﬁnity puriﬁcation. The RAT
tag consists of two hairpin stem-loops that interact speciﬁcally
with Pseudomonas aeruginosa phage 7 (PP7) coat protein. Com-
pared with the more commonly used MS2 coat protein, PP7 coat
protein maintains a high afﬁnity to its cognate RNA across a wider
range of ionic strength and pH [70,71].
5.3. 4  S1m-mediated RNA afﬁnity chromatography
Leppek and Stoecklin generated an optimized streptavidin-
binding RNA aptamer (S1 RNA9, which they termed S1modiﬁed
(4  S1m). 4  S1m has a higher afﬁnity for streptavidin compared
with previous aptamers [72]. The optimization of structure and
repeat conformation of the aptamer S1 RNA allowed an 15-fold
increase in the recovery of a reporter mRNA expressed in cells, as
compared with the established MS2 and PP7 systems. 4  S1m-
mediated RNA chromatography with a reporter mRNA containing
the AU-rich element (ARE) of mouse tumor necrosis factor a
(TNFa) has been used to purify ARE-binding proteins from cellular
extracts. Accordingly, Roquin was identiﬁed as the major protein
that interacts with the constitutive decay element (CDE), a stem-
loop RNA degradation motif located downstream of the ARE at
the 30 untranslated region (UTR) of the TNFa mRNA [73].
5.4. MS2 in vivo biotin tagged RNA afﬁnity puriﬁcation (MS2-BioTRAP)
Tsai and co-workers have developed a strategy called MS2
in vivo biotin tagged RNA afﬁnity puriﬁcation (MS2-BioTRAP) to
isolate in vivo-assembled RNP complexes [74]. In particular, this
technique was used to identify the proteins bound to internal ribo-
some entry site (IRES)-containing mRNAs rather than to canonical
mRNAs that undergo Cap-dependent translation. The principle of
MS2-BioTRAP relies on the co-expression of two vectors: one vec-
tor codes for the RNA of interest tagged with a cluster of RNA stem-
loops that can be recognized by the bacteriophage RBP MS2; and
the second vector codes for the MS2 protein fused to an HB tag
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site and a signal sequence for in vivo biotinylation — and enables
rapid and effective one-step puriﬁcation of MS2 with its associated
complexes of the stem-loop tagged RNA of interest. The biotinyla-
ted MS2 protein can then be removed from the RNP complexes
using streptavidin-coated beads or Ni-coated solid support under
native or denaturing conditions. Alternatively, RBPs can be directly
eluted upon TEV cleavage. There are a few limitations with this
method; ﬁrst of all it is only applicable in easy-to-transfect cells.
Second, the fact that one or two of the interacting molecules are
over-expressed might lead to experimental artefacts, including
mis-localization and the formation of spurious interactions or
altered activities that modify the composition of RNP complexes
Despite its limitations, we predict that the MS2-BioTrap strategy
will be widely used to analyse other RNP complexes [76–79].
5.5. RBP puriﬁcation and identiﬁcation (RaPID)
RBP puriﬁcation and identiﬁcation (RaPID) is an aptamer-based
RNA afﬁnity puriﬁcation strategy that is similar to MS2-BioTrap
[80]. The RaPID pull-down is a highly sensitive procedure that uti-
lizes a MS2-GFP-SBP fusion protein. The streptavidin-binding pro-
tein (SBP) tag allows for the puriﬁcation of RNA–protein complexes
using streptavidin-conjugated beads, while the reporter tag allows
for the localization of the RNP particle in vivo using ﬂuorescence
microscopy. By isolating tagged OXA1 mRNA using RaPID, Slobodin
and colleagues identiﬁed Sec27, a yeast COPI subunit, as a candi-
date interacting protein [81]. In addition to identifying known
and unknown proteins that interact with a speciﬁc mRNA, RaPID
puriﬁcation also enables in vivo visualization of the intracellular
localization of the RNA of interest and quantiﬁcation using western
blot analysis of the ﬂuorescent reporter. Moreover, the high-afﬁn-
ity interaction between SBP and streptavidin allows for stringent
washing of the bound RNP complexes, improving the signal-to-
noise ratio with a simple and speciﬁc elution step using biotin as
a competitor. However, RaPID shares the same shortcomings of
the previously mentioned aptamer-mediated strategy MS2-
BioTRAP.
5.6. The CRISPR Csy4 – afﬁnity system
Lee et al. generated a highly effective method of RNA–protein
complex puriﬁcation that is based on an engineered version of
the clustered regularly interspaced short palindromic repeats
(CRISPR) Csy4 endoribonuclease [82]. Csy4 recognizes a 16-nt hair-
pin sequence with a high afﬁnity (Kd = 50 pM), making its interac-
tion with target RNAs one of the highest-afﬁnity RNA–protein
interactions of this size reported to date.
An inactivate biotinylated version of Cys4 binds irreversibly to
the RNA of interest tagged with the Cys4 hairpin sequence at their
50 end. The cleavage activity of Cys4 can be inactivated without
affecting substrate binding afﬁnity or speciﬁcity and be rescued
in the presence of imidazole. Once immobilized on a solid support
Cys4 is activated to cleave the RNA removing the hairpin tag and
releasing the RNA with its bound proteins. This speciﬁc elution
via conditional enzymatic cleavage enables recovery of speciﬁc
RBPs with few false-positives. Although the authors utilized this
protocol to identify the RBPs associated to three pre-miRNAs
(pre-let-7a, pre-miR-200a and pre-miR-342) Cys4 afﬁnity puriﬁca-
tion is versatile and has a potential application in elucidating the
RBPome associated to other classes of RNA.
5.7. Interactome capture
Recently, a protocol called interactome capture has been devel-
oped by Castello and colleagues for the identiﬁcation of RBPs thatspeciﬁcally associate with mRNAs in living cells, providing a com-
plete picture of RBP activity [83].
Two recent studies revealed hundreds of novel RBPs generating
a global mRNA interactome in HeLa [84] or HEK-293 [25] cell cul-
ture systems using the interactome capture technique. Using
in vivo UV-crosslinking of RBPs to polyadenylated RNAs, covalently
bound proteins are captured with oligo(dT) magnetic beads. Fol-
lowed by puriﬁcation under stringent conditions to eliminate con-
tamination with non-crosslinked proteins and degradation of the
cellular mRNA with the use of RNAses, the polyA-bound interacto-
mes are isolated.
This method presents some notable advantages over previous
RBP identiﬁcation methods. First, nucleic acid hybridization is
stable in the presence of ionic detergents and in high-salt buffers
allowing for efﬁcient removal of polypeptides that are either asso-
ciated non-covalently with the RNA, or involved in protein–protein
interactions. Second, this protocol employs both conventional
crosslinking (cCL–254 nm) and photoactivatable-ribonucleoside-
enhanced crosslinking (PAR-CL–365 nm) in parallel taking
advantage of the crosslinking chemistries of these techniques.
Third, RNAs of interest do not require any chemical or sequence
modiﬁcation and the interacting molecules are expressed at
endogenous levels. However, this approach fails to detect RBPs
that are not expressed in the cell lines used or do not bind
polyadenylated RNAs. Moreover, several RBPs that do not directly
interact with nucleic acid bases but instead interact with other
features, such as the sugar phosphate backbone or double
stranded RNAs (dsRNAs), often lack the appropriate spatial
arrangements between RNA bases and aromatic amino acids
required for efﬁcient UV cross-linking. Furthermore, because UV
light only cross-links direct RNA–protein interactions, it cannot
capture interactions that occur through a complex of multiple
proteins. Finally, the major challenge of this method is the func-
tional validation of all identiﬁed RBPs and putative RNA-binding
domains.
5.8. Peptide nucleic acid (PNA)-assisted identiﬁcation of RBPs (PAIR)
The Peptide nucleic acid (PNA)-assisted identiﬁcation of RBPs
(PAIR) is a procedure that has been used to identify the RBPs asso-
ciated with ankylosis (ank) RNA, a panneuronal dendritically local-
ized RNA [85]. This assay utilizes speciﬁc mRNA-binding probes
(PNAs) that have the ability to cross the cell membrane of living
cells and hybridize to complementary sequences on selected
endogenous mRNAs. PNAs used in PAIR also contain the photoacti-
vatable amino acid adduct p-benzophenylalanine (Bpa), which,
after exposure of cells to UV light, can covalently cross-link with
the RBPs that are associated (located at a distance 64.5 Å) to the
RNA of interest. The PAIR technique allows for simultaneous, quan-
titative analysis of multiple RNAs and their associated RBPs in
manner that reﬂects the interactions in living cells. Compared with
the tag-mediated strategies cited before, PAIR offers the potential
to analyse the endogenously formed RNP complexes freely of any
ﬂuctuation that could have been caused by the variable expression
levels of transfected plasmids. Moreover, the PAIR technology can
enable identiﬁcation of RNPs in speciﬁc gene regions or exons
in vivo [86]. This method has the potential to be applied to any
mRNA expressed in living cell, although some mRNA sequences
may not be accessible to PNA, as a result of RNA secondary struc-
ture formation.
5.9. Afﬁnity medium
Another method for the direct isolation of RNA interacting pro-
teins uses an afﬁnity medium consisting of an artiﬁcial version of
the bait RNA. At one end, the RNA of interest is modiﬁed with an
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covalently linked on the surface of aminosilanized glass powder.
Thus the RNA is free and projected away from the matrix, facilitat-
ing its interactions with proteins. Using this method, three proteins
speciﬁcally interacting with the C/EBPb30-untranslated region
(30-UTR) RNA were isolated and identiﬁed [87].
5.10. RiboTrap
RiboTrap is the ﬁrst commercial kit developed by MBL Interna-
tional Corporation to isolate RBPs and other proteins that associate
with any speciﬁc RNA from either the cytoplasmic or nuclear
extract of cultured cells [88]. The RNA is in vitro transcribed with
5-bromo-UTP (BrUTP) and incubated with a cell lysate to form
BrU-labeled RNA–RBP complexes. These complexes are then cap-
tured using an anti-BrdUmonoclonal antibody. Differential washes
allow for analysis of both weakly- and tightly-bound RBPs. In addi-
tion, the subpopulation of mRNAs that are present in an mRNP
complex can be identiﬁed and examined for the presence of com-
mon sequence elements, such as 50 or 30 UTRs, or common func-
tional features. However, the multi-component nature of mRNP
complexes can interfere with efﬁcient immunoprecipitation
because of inaccessibility of reactive polypeptide epitopes.
The RiboTrap Kit can be also used to identify RBPs associated to
ncRNAs. However, the BrU-labeled positions and numbers in the
target sequence should be considered when performing RiboTrap
using short-length RNAs.
5.11. RNase-assisted RNA chromatography
Regardless of the puriﬁcation methods used, the required chro-
matographic support imposes technical challenges as it often
results in background noise associated with non-speciﬁc protein
binding. Usually more stringent conditions, such as increased salt
concentration in the washing step of the RNA pull-down proce-
dure, may reduce the background noise, but at the same time these
conditions can also result in the loss of important RBPs that are
weakly bound to the RNA of interest. In order to eliminate
non-speciﬁc selection, without increasing the buffer stringency,
Michlewski and Cáceres introduced the RNase-assisted RNA chro-
matography method [89]. In RNase-assisted RNA chromatography,
chromatographic support-coupled RNP complexes are treated with
a high concentration of ribonucleases during the elution step to
release only the proteins that are directly or indirectly bound to
RNA. By contrast, contaminating proteins remain bound to the
chromatographic support.
5.12. lncRNA-containing RNP (lncRNP) capture
Presently, little information is available regarding the complete
set of RBPs that are associated with a speciﬁc long non-coding RNA
(lncRNA). The molecular mechanisms underlying the functions of
lncRNAs are yet to be determined. However, many lncRNAs func-
tion through interactions with proteins, which implies the impor-
tance of identifying the RBPS associated with a speciﬁc lncRNA.
Gong and colleagues described a general procedure aimed at
retrieving cytoplasmic and poly-adenylated lncRNA-containing
RNP complexes from mammalian cells using afﬁnity puriﬁcation
[90]. The procedure relies on the insertion of the twelve copies of
the bacteriophage MS2 coat-protein binding sites into an expres-
sion vector coding for the lncRNA of interest. Cells are co-transfec-
ted with the expression plasmid and a second plasmid encoding a
FLAG-tagged MS2 coat-protein. RNPs containing the hybrid
lncRNA are then immunoprecipitated using an anti-FLAG antibody.
Formaldehyde crosslinking is used to increase the speciﬁc recovery
of lncRNA-MS2-containing RNP. By using a similar approach,Gumireddy and co-workers identiﬁed that the regulatory lncRNA
(treRNA) acts as a platform for a new ribonucleic protein complex
that inhibits translation of E-cadherin and promotes cell invasion
[91].
5.13. MS2-tagged RNA afﬁnity puriﬁcation (MS2-TRAP)
A systematic approach, termed MS2-tagged RNA afﬁnity puriﬁ-
cation (MS2-TRAP), allows for analysis of RBPs that are associated
with a target RNA in the cell [92]. The method is based on the
incorporation of MS2 RNA hairpin loops to a RNA of interest, which
is then co-expressed with an MS2 protein fused to an afﬁnity tag.
Although the authors illustrated the use of this methodology by
identifying microRNAs associated with a long intergenic (li)ncRNA
other interactions, including RNA–RNA and RNA–protein interac-
tions, can be investigated using this strategy. The MS2-TRAP
approach resembles the RiboTrap method that was developed by
Keene and colleagues [88].
5.14. Chromatin isolation by RNA puriﬁcation (ChIRP)
Chromatin isolation by RNA puriﬁcation (ChIRP) was developed
by Chu and colleagues, and allows for unbiased high-throughput
discovery of lncRNA-bound DNA and proteins [93]. This RNA-cen-
tric pull-down approach was applied for the investigation of lincR-
NAs and the lncRNA HOTAIR [94]. ChIRP combines oligo-based RNA
pull-down with deep sequencing of attached DNA. In the ChIRP
procedure, in vivo crosslinking of cultured cells is followed by
extraction of chromatin and RNA pull-down using multiple biotin-
ylated oligonucleotides covering the entire stretch of the RNA of
interest. Following isolation of DNA from the puriﬁed complexes,
the extremely high coverage of next-generation sequencing
(NGS) facilitates the detection of even small amounts of DNA. This
method is applicable to any lncRNA, without prior knowledge of its
structure or function. The PCR ampliﬁcation step prior to sequenc-
ing is responsible for the high degree of detection, which is likely to
make this NGS-based approach advantageous compared to MS-
based protein detection when using low amounts of starting
material.5.15. Capture hybridization analysis of RNA targets (CHART)
To determine the location of lncRNA interaction with chroma-
tin, Simon and colleagues developed the capture hybridization
analysis of RNA targets (CHART) method, a hybridization-based
technique that enriches endogenous RNAs and their targets within
chromatin extracts [95]. Short biotinylated oligodeoxyribonucleo-
tides that are complementary to the endogenous RNA of interest
are used for the enrichment of RBPs within the cross-linked
chromatin extracts. The RNA targets, proteins and DNA, can be
identiﬁed upon their enrichment under these conditions. A gen-
ome-wide analysis can be performed by deep sequencing the
enriched DNA.
CHART was used to identify DNA and protein associated with
lncRNAs from ﬂies and humans [96]. In addition to determining
the genomic and proteomic targets of an RNA, CHART can be used
to examine other RNAs. The enriched material can be used for an
RNA-IP, as CHART involves reversible cross-linking. CHART allows
for the enrichment of the RNA and examination of proteins associ-
ated with it instead of common pulling down protein and RNA
identiﬁcation.
Once the RBPs have been isolated from the RNA baits, the next
step is to identify the low abundant proteins of interest in a com-
plex protein solution that very often contain multiple highly abun-
dant proteins.
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Mass spectrometry (MS) is a technique used for characteriza-
tion of biological samples and its use has increased in omics stud-
ies. The improved sensitivity of MS technology has potentiated the
unbiased systematic identiﬁcation of RBPs after RNA-afﬁnity
capture.
6.1. Comparative proteomics
Comparative proteomic analysis represents the best choice to
identify RBPs interacting with a precise RNA binding site. To dis-
criminate between the unspeciﬁc proteins and the proteins of
interest, captured by the RNA bait, a control condition must be
used. This control condition must derive from a set up, where
the proteins of interest are absent from the eluate. The quality of
the data generated depends on the choice of the control condition
that must replicate the biological question. In general, proteins
puriﬁed from an RNA bait are compared with proteins captured
by a control RNA sequence, ranging from totally unrelated
sequences [97–99] to antisense sequences [100], coding sequences
[101], or even closely related sequences with a few mutated nucle-
otides [102]. The closer the control and original sequence are, the
more relevant the data will be in terms of sequence-speciﬁc inter-
actions. However, this type of controls can be provided for only
precisely-deﬁned binding sites, but not uncharacterized long
sequences.
Sample comparison can be either qualitative or quantitative.
Gel-based separations are usually used for qualitative comparisons
after RNA-afﬁnity puriﬁcation [103,104]. Prior to MS-based proteo-
mic analysis, RBPs are generally separated by gel electrophoresis in
order to reduce the complexity of samples. Subsequently, proteins
are stained with MS compatible staining, such as Coomassie blue
or the more sensitive Sypro Ruby staining, and protein bands of
interest are excised from the gel and digested with proteases prior
to MS analysis. Reducing the sample complexity is an important
step to successfully identify low abundant sequence-speciﬁc inter-
acting proteins, as it provides information about the molecular
weight of the isolated RBPs and allows for comparison with RBPs
captured by a control bait or just by the chromatographic support
itself [105]. Although gel-based protein separation remains a stan-
dard tool for proteomic research it presents substantial analytical
limitations when used for the system-wide analysis of complex
protein mixtures. A ﬁrst limitation relates to sample capacity and
detection sensitivity. A broad range of proteins binds RNA in a
non-speciﬁc manner. Although the afﬁnity of these proteins to
RNA is lower than that of sequence-speciﬁc RBPs, their abundance
is higher, and this may often result in their capture by the RNA bait.
The presence of highly abundant non-speciﬁc proteins might
impair the identiﬁcation of sequence-speciﬁc RBPs by MS when a
gel-based separation step is used. A second limitation relates to
the labour intensive nature of this method that limits its through-
put in ‘‘omics’’ studies.
Quantitative proteomic approaches that allow for simultaneous
quantiﬁcation of proteins in the sample and the control have
recently become popular. Cells are chemically or metabolically
labelled to generate differentially tagged protein pools for MS anal-
ysis, in which the isotopes of the proteins are compared to provide
direct quantiﬁcation. In chemical labelling, such as ICAT (isotope
coded afﬁnity tag labelled peptides), proteins or peptides are
tagged through a chemical reaction [106], whereas in metabolic
labelling, such as SILAC (stable isotope labelling by amino acids
in cell culture), the label is introduced to the whole cell through
the growth medium [107]. The advantage of the quantitative
approach is that the ratios of peptides from the experimental and
control samples can be directly compared to separate true bindingpartners from non-speciﬁc interactions. In this way, when using a
system with high background a quantitative MS approach can pro-
vide increased ability to discriminate between speciﬁc and non-
speciﬁc binders.
6.2. Non-comparative proteomics
When the goal is to identify all the proteins interacting with a
speciﬁc RNA sequence and the key binding sites have not been
deﬁned the approach is different. Long lists of putative candidates
are generated from MS analysis following large-scale unbiased
long RNA afﬁnity puriﬁcation. The major difﬁculty is to determine
sequence-speciﬁc and unspeciﬁc interacting proteins from the
lists.
The long RNA bait may capture a very large number of different
proteins, and the low abundant sequence-speciﬁc RBPs may
become undetectable. Therefore, gel-free approaches are recom-
mended, as they enable improved chromatographic separation of
the complex peptide mixture prior to the MS analysis [108]. Such
shotgun approaches include the reduction of sample complexity
through liquid chromatography, multidimensional fractionation,
or the multidimensional protein identiﬁcation technology (Mud-
PIT) combining strong cation exchange chromatography with
reverse phase chromatography [109]. Although these novel
approaches facilitate high-throughput analyses of the proteome
of a cell type and provide an overview of the major protein constit-
uents, they should be used as complements of gel-based
approaches.
RAP-MS analysis has been used to identify the RNA-binding
proteome that is associated with different classes of RNA, including
mRNA and ncRNAs. There are several analytical challenges for
identifying proteins associated with an RNA molecule by RAP-
MS. First, RNA is unstable and ﬂexible, which impedes not only
the isolation of RNA-bound proteins but also the design of func-
tional tags or antisense oligonucleotides. Second, RAP approaches
require a signiﬁcant amount of starting material to isolate enough
proteins for detection. Third, the amino acid sequence of proteins
that interact with bait RNA cannot be ampliﬁed, complicating the
identiﬁcation of binding partners of individual low abundance
RNAs. Finally, one major concern when aiming to isolate and char-
acterize endogenously assembled RNP complexes is the phenome-
non of post-lysis re-organization [110]. As native RNA–protein
interactions are expected to be dynamic and highly sensitive to
conditions such as ionic strength, precise concentrations and sub-
cellular localization, co-puriﬁcation cannot be assumed to neces-
sarily reﬂect an endogenous interaction [111]. To circumvent this
problem, methods such as UV or chemical crosslinking should be
used to stabilize endogenous RNP complexes prior to cell lysis.
Improvements in RNA-afﬁnity puriﬁcation and characterization
of RBPs will facilitate the study of composition, stoichiometry and
dynamic of RNA-interacting complexes. Although this represents
the future directions in this ﬁeld, they currently suffer from limita-
tions in the sensitivity of the MS identiﬁcation.
Simultaneous to the development in RAP strategies, new RNA-
ligand assays have emerged in the literature.7. RBP screening within protein libraries
In vitro or in vivo screening for RNA sequence-speciﬁc proteins
within large libraries is a high-throughput approach to identify
RBPs associated to an RNA of interest (Fig. 2).
Three main steps are at the basis of all RBPs screening strate-
gies: the construction of a gene library (genotype); the establish-
ment of a linkage between each protein (phenotype) and its
encoding gene (genotype); and the selection of desired proteins
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be subject to iterative rounds of selection followed by ampliﬁca-
tion of the selected sub-library. As potential target proteins are
overexpressed from expression vectors, these techniques can usu-
ally identify interacting proteins even when they are expressed atvery low endogenous levels and thus difﬁcult to detect using tradi-
tional-biochemical methods.
In vivo systems can select for function in the context of cellular
processes, whereas in vitro approaches have greater control over
binding conditions upon sampling larger libraries and reduced
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identiﬁcation of rare sequences, and also improves the diversity
of the selected sequences. Finally, in vitro selection methods allow
for in vitro mutagenesis [112] and recombination techniques dur-
ing the process.
7.1. The yeast three-hybrid system
The yeast three-hybrid system is a useful tool for studying
RNA–protein interactions in S. cerevisiae independent of the biolog-
ical role of the RNA or protein [112]. This assay is a variation of the
yeast two-hybrid system and has been successfully used to test
candidate RNA–protein pairs, to identify RNA sequences that bind
known RBPs, and to analyse RNP complexes. The system is based
on the formation of a multi-subunit trans-activator complex that
involves RNA–protein interactions, upstream of reporter genes in
yeast cells (Fig. 2a). The reliability of this method originates from
its ability to detect different strengths of RNA–protein interactions,
based on the use of two reporter genes. One widespread use of the
yeast three-hybrid system has been to discover proteins that bind
to a given RNA sequence [113]. To date, nearly 40 RBPs have been
successfully selected and characterized using this method.
One of the most pivotal advantages of this method is that the
interactions can be monitored in vivo and the signal can be
enhanced. However, some important limitations of the yeast
three-hybrid system need to be taken into account. Some proteins
require post-transcriptional modiﬁcations in the RNAs to be able to
bind them. These RNAs and proteins are not suitable to be studied
with the yeast three-hybrid system, as such modiﬁcations may not
occur in the hybrid RNA. In addition, some RNAs can contain
localization signals that can target it to outside the nucleus,
preventing it from triggering the reporter gene activation. Finally,
the biggest problem of the yeast three-hybrid screen is the selec-
tion of false positive clones that must be resolved upon additional
time-consuming screening steps, limiting the ability to identify
new targets on a genomic scale.
7.2. Bacterial assays
Bacterial assays exploiting RNA binding to cause transcriptional
anti-termination or interference in translation have been recentlyFig. 2. Screening of RBPs within protein libraries. Schematic representation of the most po
basis of all RBPs screening strategies: the construction of a gene library; the establishm
desired proteins from the library, followed by ampliﬁcation and identiﬁcation of the sel
protein containing a DNA-binding domain with RNA-binding domain 1 localizes to the
transcriptional activation domain with RNA-binding domain 2 will activate transcriptio
sequences. A hybrid RNA containing sites recognized by the two RNA-binding proteins
detectable expression of the reporter gene. Yeast triple transformants are assayed by as
sequencing. (b) Bacterial anti-termination assay. Simpliﬁed overview of the two-plasmid
polypeptides fused to the N protein. The ability to select for survival at different kanamy
afﬁnities. (c) Tat-hybrid assay. A cDNA library is fused to the activation domain of Tat a
reporter in which TAR is replaced by an RNA of interest. The Tat-fusion cDNA library is de
the expression of the reporter gene. For instance, by using a GFP reporter, GFP-expressing
isolated and individual clones are ampliﬁed and sequenced. In vitro approaches. (d) North
library clones expressing proteins that engage in sequence-speciﬁc interactions with the
nitrocellulose or nylon membrane is pressed against the surface thereby adsorbing pha
radiolabelled RNA probe. After hybridization, the probe solution is removed, and the ﬁlt
strong radioactive signals is related back to a master plate containing the original patt
ampliﬁed and identiﬁed. (e) In vitro compartmentalization. Single genes are compartme
afﬁnity puriﬁcation. After breaking the emulsions, streptavidin-coated magnetic beads
encoding DNA. The selected gene expression cassettes are subsequently ampliﬁed and id
fusions to coat proteins. In phage library selections, RBP-speciﬁc clones can be selected b
Retained phage can be ampliﬁed and individual binding clones can be subjected to DNA
DNA library is transcribed into RNA, which is subsequently translated into mRNA-display
selection targets for several rounds. Following binding selection, those library memb
identiﬁcation. (h) Protein microarray. Speciﬁc RNA of interest is synthesized in vitro, l
proteins interacting preferentially with individual RNA are identiﬁed.
3devised. A bacterial genetic assay for detecting polypeptide–RNA
interactions was used to screen combinatorial libraries for novel
arginine-rich peptides that bind to the Rev-response element
(RRE) of human immunodeﬁciency virus (HIV) [114]. The method
utilizes the transcription anti-termination activity of the bacterio-
phage k N protein, which causes RNA polymerase to read through
transcription termination sites by forming an anti-termination
complex [115,116].
Peptide libraries fused to the N protein are encoded on one plas-
mid, and a second reporter plasmid engineered with an RNA site of
interest allows for identiﬁcation of those proteins that bind the
RNA of interest (Fig. 2b).
The anti-termination system enables the identiﬁcation of tight
RNA-binding peptides from mixtures of peptides that have a wide
range of afﬁnities toward a particular RNA target. However, the
anti-termination system produces a relatively high rate of false
positives and to date it has used only short arginine-rich sequences
as frameworks for generating protein libraries.7.3. Mammalian Tat-hybrid system
In order to overcome the limitation of using artiﬁcial environ-
ments or microorganisms, a mammalian cell-based assay using
the Tat-hybrid system has been recently developed to identify
RBPs within cDNA libraries. The Tat-hybrid system is based on
the transcriptional activation properties of the human immunode-
ﬁciency virus type 1 (HIV-1) trans-activator protein (Tat). Tat is a
potent activator of viral gene transcription, and acts by binding
to the trans-activating responsive (TAR) element, a long imperfect
RNA hairpin placed at the 50 end of the RNA [117]. Tat can activate
transcription through heterologous RNA–protein interactions
when bound to the RNA [118]. Thus, by fusing a library to Tat,
replacing TAR with bait RNA and using an HIV LTR reporter, it is
possible to screen for RBPs by (Fig. 2c). Using this approach and
a GFP reporter, Tan and Frankel identiﬁed novel arginine-rich pep-
tides that bind to the Rev response element of HIV [119]. Moreover,
Nakamura and colleagues identiﬁed several proteins that interact
with an RNA hairpin, which is named Mason Pﬁzer monkey virus
(MPMV) constitutive transport element (CTE) and is responsible
for the transport of unspliced viral mRNA from the nucleus topular strategies for screening RBPs within gene libraries. Three main steps are at the
ent of a linkage between each protein and its encoding gene and the selection of
ected gene sub-library. In vivo approaches. (a) Yeast three-hybrid system. A hybrid
promoter of an appropriate reporter gene. A second hybrid protein containing a
n of the reporter gene when in close proximity to the gene’s upstream regulatory
links the two hybrid proteins to one another, and the tripartite complex results in
says of report genes. The identity of the RNA-dependent positives is determined by
system for detecting transcription anti-termination by heterologous RNA-binding
cin concentrations allows for the identiﬁcation of clones with varying RNA-binding
nd the RNA-binding proteins are identiﬁed by their ability to activate an HIV-1 LTR
livered in reporter cell lines. The interaction between the RNA bait and RBPs induces
cells can be isolate by ﬂuorescence activated cell sorting. Plasmids are subsequently
western screening. The screen utilizes short 32P labelled RNA probes to isolate cDNA
probe. Plaques of recombinant phage are allowed to form on a bacteria lawn. Then a
ge from the plaques in a replica pattern. The membrane is then screened with the
er is washed extensively, dried and submitted to autoradiography. The position of
ern of colonies, in order to identify positive colonies. The desired clones are then
ntalized in water-in-oil emulsions and translated in vitro. RBPs are then selected by
bound with biotin-labeled RNA were used to capture the RBPs and corresponding
entiﬁed. (f) Phage display. Libraries of proteins are displayed on phage particles as
y binding to immobilized target followed by washing to remove non-binding phage.
sequencing to decode the sequences of the displayed proteins. (g) mRNA display. A
ed proteins. The mRNA/DNA-polypeptide fusions can be selected over immobilized
ers that stay bound to the immobilized target are ampliﬁed and sequenced for
abelled with Cy-dyes and bound to a protein microarray. In subsequent analyses,
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RNA–protein interactions are studied in vivo in a mammalian cell,
where any possible required accessory factors, chaperons and
post-translational modifying enzymes are available to help in the
complex reassembly. For this reason this screening method is
particularly appropriate for studying mammalian complexes that
may require post-translational modiﬁcations or multiple cellular
components for binding. On the other hand, large domains fused
to Tat may sterically hinder the formation of transcription
elongation complexes and it is also possible that endogenous
nuclear proteins or RNAs may compete for RNA binding, thereby
preventing activation.7.4. Northwestern technology
Northwestern technology is a powerful in vitro tool to obtain
cDNA clones of proteins that speciﬁcally interact with deﬁned
RNA sequences [121]. The screen utilizes short 32P labelled RNA
probes to isolate cDNA library clones expressing proteins that
engage in sequence-speciﬁc interactions with the probe (Fig. 2d).
The rationale of this screening approach is based on the plaque lift
technique originally used for screening cDNA libraries constructed
in bacteriophages [122]. Sägesser and colleagues improved this
screening protocol taking advantage of the well-characterized
human U1A/U1-RNA model system for RNA–protein interaction
[123]. Afterwards, they successfully applied this screening protocol
for the characterization of RBPs that speciﬁcally interact with the
potato spindle tuber viroid (PSTVd) RNA [124].
This method is rapid and inexpensive. It requires basic informa-
tion about the speciﬁc RNA of interest and does not require knowl-
edge of the amino acid sequences of the putative RBPs. However,
multiple factors can interfere with the assay sensitivity, especially
plaque size and density, the type of probe used, the number and
complexity of the target sequence and the properties of the solid
phase.7.5. In vitro compartmentalization (IVC)
In vitro compartmentalization (IVC) is a cell-free screening sys-
tem that generates ‘‘artiﬁcial cells’’ for the directed evolution of
proteins [125]. IVC utilizes micro-compartments for genotype-
phenotype linkage, unlike any other techniques used in conven-
tional in vitro display. These cell-like compartments are aqueous
droplets of water-in-oil (w/o) emulsions, where on average each
droplet contains a single gene and resembles an artiﬁcial cell in
enabling transcription and translation of the resulting proteins to
occur (Fig. 2e). Chen and colleagues demonstrated for the ﬁrst time
the application of the IVC method to identify RBPs by exploiting
the well-known interaction between zinc-ﬁnger proteins and their
encoding DNA sequences [126].
One major advantage of IVC is that the expressed protein does
not need to be directly bound to the nucleic acid. This precludes
any type of modiﬁcation in the protein preventing the alteration
of its activity. Additionally, the high capacity of IVC, the ease of
preparing emulsions, and stability over a broad range of temper-
atures, makes IVC emulsions an attractive reaction vessel for
screening very large gene libraries without cloning and trans-
forming steps. However, some technical limitations must be
considered [127]. The ﬁrst is the stringency of the genotype-
phenotype link since it is possible to form double emulsion drop-
lets containing multiple compartments encapsulating unrelated
genes [128]. The second limitation is a technical issue when using
membrane proteins or any other protein that requires post-
translation modiﬁcation [129].7.6. Phage and mRNA display
Phage display andmRNA display have been used to identify var-
iant domains of RBPs that bind to RNAs with altered speciﬁcities.
Phage display involves the insertion of a gene encoding a pro-
tein of interest into a phage coat protein gene, causing the phage
to display the protein on its outside while containing the gene
for the protein on its inside, resulting in a connection between
genotype and phenotype (Fig. 2f). In this way, by immobilizing
an RNA target to beads or to the surface of a microtiter plate well,
large protein libraries can be screened against the RNA target and
ampliﬁed in a process called in vitro selection. Phage display has
been successfully used to investigate the RNA-binding speciﬁcity
of the mammalian spliceosomal protein U1A, which binds to hair-
pin II of the U1 small nuclear RNA (U1hpII) [130], as well as to iso-
late single zinc ﬁngers that bind complex RNA structures with high
afﬁnity and speciﬁcity [131]. A number of phage libraries display-
ing cyclic peptides and linear peptides are commercially available.
However, the size of the libraries is limited by the transformation
efﬁciency of bacterial cells and only a limited number of individual
clones can be examined easily making this method time-consum-
ing, difﬁcult to scale-up and labour-intensive. mRNA display, also
called mRNA–protein fusion [132] or in vitro virus [133], relies
on the covalent coupling of mRNA to the nascent polypeptide
(Fig. 2g). Numerous mRNA-display selections have isolated more
than one hundred chemically distinct RNA-binding peptides
[134]. Most of the experiments have used the RNA-binding domain
from phage k N protein owing to its small size and high afﬁnity for
its cognate RNA. Despite its advantages, mRNA display has some
limitations. The major concerns are the possibilities that the cova-
lently attached mRNA interferes with the function of the protein,
or that the target RNA interacts with the displayed protein. Other
weaknesses of mRNA display are limitations in the display of mem-
brane-bound proteins owing to their low expression level in
in vitro translation systems [135] and of proteins whose biological
functions relies on complex formation.
7.7. Protein microarrays
Protein microarrays have been used to screen for known pro-
teins that unexpectedly interact with a speciﬁc RNA in vitro. This
approach involves the labelling of the RNA target with ﬂuorescent
dyes, such as the cyanine Cy3 or Cy5, and their subsequent screen-
ing with a ﬂuorescence scanner (Fig. 2h).
Two studies using protein microarrays and RNA probes to
search for new RNA-binding proteins in yeast identiﬁed approxi-
mately 200 unexpected RBPs [136,137]. Interestingly, more than
half of the identiﬁed proteins are well known enzymes, and many
of them involved in RNA metabolism. This study indicated direct
connections between metabolic status and post-transcriptional
gene regulation. Moreover, most of the RBPs identiﬁed lack recog-
nizable RNA-binding domains, which underlies the limitations of
current bioinformatics methods that rely upon homology to known
RNA binding domains. Recently, Siprashvili and colleagues used
human protein microarrays to identify 137 RNA–protein interac-
tions speciﬁc for 10 coding and non-coding RNAs [138]. In partic-
ular, Stau1, a well-known RNA-binding protein involved in RNA
stability and localization [139], was found to interact with a
256 bp sequence of the TP53 30 UTR, regulating TP53 mRNA in a
previously uncharacterized way.
The use of protein arrays to monitor RNA–protein interactions
has several advantages. As hundreds and even thousands of pro-
teins can be analysed simultaneously in a single experiment, it is
a very effective high-throughput method taking less than a day
to complete. The reagents required are readily available, such as
many commercial protein arrays. Moreover, the assay requires a
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isolation. Although protein arrays encompass a broad range of
applications on a proteome scale, the greatest limitation to their
utility is that the quality of the data obtained from screening a pro-
tein array depends on a complete and functional representation of
proteins on the chip. Misfolded proteins or inaccessible protein-
binding domains may lead to false-negative or false-positive
results. As the expression and analysis of RNA–protein interactions
are carried out in an artiﬁcial environment relative to the cell there
is not always a direct correlation between protein abundance and
activity. Moreover, this artiﬁcial environment may not represent
the physiological conditions of the biological system under study.
Screening for RNA sequence-speciﬁc proteins using large
libraries has a higher sensitivity in comparison to the MS-based
afﬁnity strategies and allows for the identiﬁcation of poorly
expressed RNA-binding proteins. However, except for the mamma-
lian Tat-hybrid system, these methods are limited to binary inter-
actions, and interactions that require speciﬁc post-translational
modiﬁcations are likely to be missed. For this reason detection of
cDNA clones from large libraries encoding any possible RNA-bind-
ing proteins has not yet become a consolidated ribonomic strategy.
Moreover, these methods present some restrictions regarding the
size of the RNA target, and almost all of them are not appropriate
to investigate full-length transcripts or long RNAs.
Regardless of the RNA-centric approaches used, relevant RBP
candidates should be identiﬁed from several independent biologi-
cal replicates followed by functional validation. Indeed, due to the
high afﬁnity RNA binding from some proteins [103,140], the candi-
date interacting proteins must undergo further biological valida-
tions. For instance, computational approaches can be an excellent
complement to experiments by either suggesting new targets of
investigation or providing independent validation and ranking of
experimental results.
8. Computational methods
In parallel to the progress made in methods for experimentally
mapping RNA–protein interactions, the development of bioinfor-
matic tools has improved the in silico prediction of such interac-
tions. However, whereas the methodology for prediction and
modelling of proteins and protein–protein complexes is well estab-
lished [141,142], there are fewer methods capable of predicting
and modelling RNA and RNA–protein complexes [143,144].
Ideally, the prediction of RNA–protein complex structure should
be based on the knowledge of atomic structures of the compo-
nents, as determined by X-ray crystallography, Cryo-electron
microscopy (Cryo-EM) or Nuclear Magnetic Resonance (NMR)
spectrometry. Single molecule studies using FRET pairs can deter-
mine either the dynamics or the force-versus-extension traces
within the RNA. In addition, different structure-speciﬁc probe
methods, such as dimethyl sulfate (DMS) [145], hydroxyl radical
footprinting [146], or the 20-hydroxyl acylation RNA (SHAPE)
[147,148], can be used for predicting RNA secondary structures.
As experimentally determined structures of components of the
complex are not available in many cases, computationally-mod-
elled structures can be used instead. To this end, a great number
of softwares have been developed that allow for reasonably accu-
rate and practically useful prediction of RNA 3D structures and
interactions.
Over the past three decades several computational programs
have been developed for the prediction of RNA secondary struc-
tures. Multiple approaches have been used including: free energy
minimization using thermodynamic parameters, such as Mfold
[149] and RNAfold [150]; knowledge-based predictions based on
known RNA structures, such as Contrafold [151] and RNAShapes[152]; comparative sequence alignment algorithms, such as Dyn-
align [153] and RNAforester [154]; and combinations of these.
RNA tertiary-structure predictions programs have also emerged
in order to overcome some of the limitations of the previously cited
programs. Some of the most recently available programs for RNA
tertiary-structure predictions include FARNA [155], NAST [46],
iFoldRNA [156] and RNA2D3D [157].
Several software tools can be used to predict RNA-binding res-
idues from protein sequence alone or from protein structure. Some
indicative examples include RNA BindR Plus [158], OPRA [159],
DRNA [160] and KYG [161]. In addition, various methods have been
established for the identiﬁcation of potential protein–RNA docking
sites. These are modiﬁcations of methods used to identify protein–
protein docking sites that view nucleic acid molecules as receptors
and/or ligands, instead of proteins. Such methods include HAD-
DOCK [162], GRAMM [163], HEX [164], PatchDock [165], and
FTDock [166]. Only recently, the docking method called 3dRPC
[167] that takes special features of RNA surfaces into account
was developed with a speciﬁc purpose of identifying protein–
RNA docking sites.
Finally, Tartaglia and colleagues developed catRAPID, the ﬁrst
computational method capable of predicting RNA–protein interac-
tions in a large scale [168]. The algorithm evaluates the interaction
propensities of polypeptide and nucleotide chains based on physi-
cochemical properties such as secondary structure information,
hydrogen bonding and Van der Waals forces. Moreover, the
authors validated their algorithm on a large collection of protein
associated with lncRNAs, the NPinter dataset [169]. However, pre-
diction of lncRNAs function is generally hampered by poor
sequence homology and lack of interaction data.
Computational approaches are highly needed for predicting the
RNP interactome and complement experimental methods. These
bioinformatic tools should be useful to uncover and extend the
network of RBPs, thus achieving better understanding of RNA biol-
ogy. Over the last decade, great advances have been made in ribo-
nomic approaches, computational softwares and technologies for
RNA investigations. However, both RNA-based computational
approaches as well as ribonomic RNA-centric methods require fur-
ther technical developments and reﬁnements.
Development of computational methods able to predict RNP
structures, either from the individual components or directly from
their sequences has been highly sought owing to the difﬁculty in
the structure determination of RNA–protein complexes. The exist-
ing approaches for RNP modelling can provide useful predictions
despite their various limitations. One problem speciﬁc to RNA
modelling is the relative paucity of experimentally-determined
RNA and RNP structures that can be used as templates. Another
limitation is related with the fact that docking programs seldom
take into account conformational changes that may occur upon
binding, both in protein and RNA components.
9. Conclusions and future directions
Exciting new discoveries have revealed the complex versatility
of RNPs and their importance in a large number of functions within
the cells. The broad characterization of RNP components, interac-
tions, dynamics and function are fundamental steps in required
to uncover the role of post-transcriptional regulation in gene
expression. Understanding the effects of linked gene regulatory
networks on cellular function, organism development and the evo-
lution of biological complexity will be achieved with more compre-
hensive analysis.
The combination of ribonomic approaches with cross-linking
techniques and high-throughput sequencing has provided a
systematic mapping of RBP-binding sites [40,170,171]. Next
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titative detection of RNAs, including rare and previously
unknown RNA molecules [172]. Novel large-scale proteomic
approaches now enable the quantitative measurement of hun-
dreds of proteins in parallel [173,174]. Concomitant analysis of
the changes in the RNA and protein levels upon RBP depletion
or overexpression could therefore provide global information of
the different status of mRNAs and of their downstream effects
[175,176].
However, little information is available regarding the full
complement of RBPs that are associated with a speciﬁc RNA. Such
information will be important to unravel the combinatorial
regulation of mRNAs by multiple RBPs and understand how the
assorted RBPs change with environmental cues. This becomes
even more important in light of the rapidly increasing
number of ncRNAs – in particular the lncRNAs – that play
important roles for gene expression control in cell-differentiation
and development.
Elucidating the composition of RNPs requires technological
advances in RNA-centric high-throughput methods [177,178], as
well as reﬁnements in bioinformatics tools. Future steps are
needed to obtain a complete picture of the ribonome. As knowl-
edge of post-transcriptional RNA operons increases, surely new
functions for multifunctional proteins and connections within reg-
ulatory pathways will be uncovered, but this is a difﬁcult task to
achieve with traditional methods.
A ﬁrst barrier to understanding RNPs is the identiﬁcation and
characterization of their total RNA and RBP components [179]. As
the number of known RNA–protein interactions increases, the
binding and localization of RBPs over the genome and transcrip-
tome will begin to be better evaluated. Fast identiﬁcation of all
proteins bound to an individual RNA of interest will provide a dee-
per characterization of the molecular mechanisms and the func-
tional role of virtually any speciﬁc coding and non-coding RNAs
involved in human diseases.
Furthermore, a comprehensive understanding of RNP biology
will require speciﬁc knowledge of the interplay between different
inputs and each component of the system and how they play their
role in controlling and regulation. RNP biology needs to focus on
the dynamics of post-transcriptional processes and their interac-
tions on a large scale rather than the old static analysis of individ-
ual component interactions. The RNA–protein network appears to
be very dynamic and responds to environmental or developmental
signals by altering the RNA and protein content of RNPs. Thereby,
post-translational modiﬁcations can alter subcellular localization
or RNA-binding activity of the RBP [180,181]. The RNA–protein
network is further complicated by the possibility that multiple
states of a speciﬁc mRNA population may exist and therefore not
every RNA molecule may have the same fate. RNP systems are nor-
mally studied within cell populations and therefore reﬂect the cell
average [182]. Single cell approaches may provide a better deﬁni-
tion of RNP interactions and compositions within individual cells.
Such studies are necessary to provide a deeper understanding of
the RNPs function from individual cells to tissues, and multicellular
organisms. Ribonomic analysis can identify the emerging of new
RNA-binding domains during evolution upon studies of samples
from multiple species.
Finally, a major challenge ahead will be the analysis, visualiza-
tion and integration of a large scale data from different levels of
gene expression, which in turn will provide new insights into their
cellular and physiological function. A robust understanding of RNP
system biology will rise from a large-scale data integration on RNP,
protein–protein and RNA–protein interactions, protein and tran-
script levels, protein and RNA localization and RNP dynamics
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